FDA Inspection 1326372 — Linde Inc.

Linde Inc. — FEI 1216060

The FDA completed an inspection of Linde Inc. on Jun 17, 2026 in Suffield, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 17, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Suffield, CT (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.